Skip to main content

MoneyWorks4Me

Glenmark Life Sciences informs about disclosure

26 Sep 2023 Evaluate
Glenmark Life Sciences has informed that it enclosed the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Nirma.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1860.00
Dr. Reddys Labs. 1371.20
Cipla 1409.00
Lupin 1990.00
Zydus Lifesciences 1195.00
View more..